Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferdinando Fusco

Showing results (41-50 of 168) with videos related to

Pageof 17
Sort By:
Advances in Therapy|March 4, 2017
Benign Prostatic Obstruction Relief in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Enlargement Undergoing Endoscopic Surgical Procedures or Therapy with Alpha-Blockers: A Review of Urodynamic StudiesFerdinando Fusco, Massimiliano Creta, Vittorio Imperatore, et al.
Asian Journal of Andrology|May 9, 2007
Evaluation of an alternative dosing regimen with tadalafil, three times per week, for men with erectile dysfunction: SURE study in ItalyVincenzo Mirone, Ciro Imbimbo, Andrea Rossi, et al.
Urologia|May 22, 2012
[Impact of preoperative therapy with 5-α-reductase inhibitors in the treatment of benign prostatic hyperplasia]Giacomo De Stefano, Ferdinando Fusco, Davide Arcaniolo, et al.
European Urology|July 31, 2012
Sildenafil effect on the human bladder involves the L-cysteine/hydrogen sulfide pathway: a novel mechanism of action of phosphodiesterase type 5 inhibitorsFerdinando Fusco, Roberta d'Emmanuele di Villa Bianca, Emma Mitidieri, et al.
The Journal of Urology|September 17, 2004
Correlation between detrusor collagen content and urinary symptoms in patients with prostatic obstructionVincenzo Mirone, Ciro Imbimbo, Gaetano Sessa, et al.
Urologia Internationalis|December 1, 2010
Radical perineal prostatectomy versus radical retropubic prostatectomy after previous prostate surgery: surgical and functional outcomesVittorio Imperatore, Francesco Cantiello, Ferdinando Fusco, et al.
Neurourology and Urodynamics|April 1, 2018
Alpha-1 adrenergic antagonists, 5-alpha reductase inhibitors, phosphodiesterase type 5 inhibitors, and phytotherapic compounds in men with lower urinary tract symptoms suggestive of benign prostatic obstruction: A systematic review and meta-analysis of urodynamic studiesFerdinando Fusco, Massimiliano Creta, Cosimo De Nunzio, et al.
Asian Journal of Andrology|August 25, 2009
Patterns of treatment with PDE5 inhibitors in the clinical practice in Italy: longitudinal data from the Erectile Dysfunction Observational StudyFerdinando Fusco, Riccardo Sicuteri, Andrea Rossi, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|June 19, 2020
The urothelium, the urinary microbioma and men LUTS: a systematic reviewRiccardo Lombardo, Giorgia Tema, Jean N Cornu, et al.
The Journal of Sexual Medicine|January 21, 2006
Flexible-dose vardenafil in a community-based population of men affected by erectile dysfunction: a 12-week open-label, multicenter trialVincenzo Mirone, Alessandro Palmieri, Domenico Cucinotta, et al.
Pageof 17

Showing results (41-50 of 168) with videos related to

Sort By:
Pageof 17
Advances in Therapy|March 4, 2017
Benign Prostatic Obstruction Relief in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Enlargement Undergoing Endoscopic Surgical Procedures or Therapy with Alpha-Blockers: A Review of Urodynamic StudiesFerdinando Fusco, Massimiliano Creta, Vittorio Imperatore, et al.
Asian Journal of Andrology|May 9, 2007
Evaluation of an alternative dosing regimen with tadalafil, three times per week, for men with erectile dysfunction: SURE study in ItalyVincenzo Mirone, Ciro Imbimbo, Andrea Rossi, et al.
Urologia|May 22, 2012
[Impact of preoperative therapy with 5-α-reductase inhibitors in the treatment of benign prostatic hyperplasia]Giacomo De Stefano, Ferdinando Fusco, Davide Arcaniolo, et al.
European Urology|July 31, 2012
Sildenafil effect on the human bladder involves the L-cysteine/hydrogen sulfide pathway: a novel mechanism of action of phosphodiesterase type 5 inhibitorsFerdinando Fusco, Roberta d'Emmanuele di Villa Bianca, Emma Mitidieri, et al.
The Journal of Urology|September 17, 2004
Correlation between detrusor collagen content and urinary symptoms in patients with prostatic obstructionVincenzo Mirone, Ciro Imbimbo, Gaetano Sessa, et al.
Urologia Internationalis|December 1, 2010
Radical perineal prostatectomy versus radical retropubic prostatectomy after previous prostate surgery: surgical and functional outcomesVittorio Imperatore, Francesco Cantiello, Ferdinando Fusco, et al.
Neurourology and Urodynamics|April 1, 2018
Alpha-1 adrenergic antagonists, 5-alpha reductase inhibitors, phosphodiesterase type 5 inhibitors, and phytotherapic compounds in men with lower urinary tract symptoms suggestive of benign prostatic obstruction: A systematic review and meta-analysis of urodynamic studiesFerdinando Fusco, Massimiliano Creta, Cosimo De Nunzio, et al.
Asian Journal of Andrology|August 25, 2009
Patterns of treatment with PDE5 inhibitors in the clinical practice in Italy: longitudinal data from the Erectile Dysfunction Observational StudyFerdinando Fusco, Riccardo Sicuteri, Andrea Rossi, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|June 19, 2020
The urothelium, the urinary microbioma and men LUTS: a systematic reviewRiccardo Lombardo, Giorgia Tema, Jean N Cornu, et al.
The Journal of Sexual Medicine|January 21, 2006
Flexible-dose vardenafil in a community-based population of men affected by erectile dysfunction: a 12-week open-label, multicenter trialVincenzo Mirone, Alessandro Palmieri, Domenico Cucinotta, et al.
Pageof 17